Funding news for global health researchers: December 9, 2024

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Special Announcements

New mHealth Opportunity from Fogarty

The overall goal of the program is to develop an evidence base for the use of mHealth technology to improve clinical and public health outcomes, and strengthen mHealth research capacity in LMICs.This NOFO provides support for up to two years for technology development and feasibility studies, followed by a possible transition to expanded research support for validation, larger-scale feasibility, and effectiveness studies.

• Application due date: March 21, 2025; March 20, 2026
• Read funding opportunity (PAR-25-242)
• Learn more about the mHealth program

Join NIMHD for a Pre-Application Webinar

NIMHD will host a public pre-application webinar for the Fogarty-partnered  Minority Health and Health Disparities Research Training (MHRT) Program (T37) funding opportunity. The webinar will provide an overview of program goals and technical guidance, with time for Q&A.

• Webinar date: Friday, December 13, 2024, from 1:00–2:30 p.m. (EST)
• More information

NCI Seeks to Fund Implementation Science in LMICs

The National Cancer Institute (NCI) has released a notice of special interest (NOSI) to inform potential applicants of its interest in supporting implementation research related to cancer prevention and control in low- and middle-income countries (LMICs). NCI encourages applications that pursue innovative approaches to identifying, understanding, and developing strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, tools, policies, and guidelines in low-resource settings.

• Read full notice of special interest (NOSI) (NOT-CA-25-012)
• First available due date: January 5, 2025
  
• Expiration date: January 8, 2028

Fogarty-partnered NIMHD Research Training Program Now Accepting Applications

The NIMHD Minority Health and Health Disparities Research Training (MHRT) Program supports research training activities that are consistent with the mission of NIMHD. The program helps ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address the Nation's need to advance scientific research to improve minority health and reduce health disparities.

• Application due date: January 10, 2025
• Read funding opportunity (RFA-MD-25-001)

NIH Interested in Implementation Science for Climate Change and Health

The NIH Climate Change and Health Initiative (CCHI), an urgent, cross-cutting NIH effort to stimulate research to reduce health threats from climate change across the lifespan, is seeking applications that propose implementation studies to understand and address barriers and facilitators to the adoption, implementation, scale-up, and sustainment of effective interventions to prevent or mitigate the health effects of climate change in the United States and globally.

• Read Notice of Special Interest (NOT-CA-25-003)
• Expiration date: January 8, 2028

Upcoming Deadlines for Fogarty Funding Opportunities

• Stigma HIV/AIDS
  Application deadline: December 20, 2024
  
• Japanese Research Fellowships (JSPS)
  Application deadline: February 14, 2025
  
• International Research Scientist Development Award (IRSDA)
  Application deadline: March 10, 2025
  

Upcoming deadlines for all Fogarty funding opportunities

Funding opportunities on which Fogarty is a partner:

• Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) (PAR-25-233)
  Application due date: Multiple dates, see announcement.
• Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) (PAR-25-143)
  Application due date: Multiple dates, see announcement.

Administrative supplements for current Fogarty grant recipients:

• Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional) (NOT-OD-25-015) 
  Expiration date: January 24, 2025
  
• Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) (PA-20-272) 
  Expiration date: January 24, 2025
  
• Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards (NOT-OD-23-032) 
  Expiration date: October 1, 2025
  
• Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) (PA-23-189) 
  Expiration date: May 8, 2026
  

All administrative supplements

Funding Opportunities

NIH funding opportunities focusing on global health and foreign collaboration:

• Integrating Mental Health Care into Health Care Systems and Non-Health Settings in Low- and Middle-Income Countries (R01 Clinical Trial Optional) (PAR-25-201)
  Application due date: Multiple dates, see announcement.
• Career Development Opportunities for Research on Cancer in Global Settings at the Center for Global Health at the National Cancer Institute  (NOT-CA-24-098)
  Application due date: Multiple dates, see announcement.
• Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Income Countries (LMICs) for Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Research (R03 Clinical Trial Not Allowed) (RFA-AG-25-031)
  Application due date: Multiple dates, see announcement.
• Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries (U01 Clinical Trial Not Allowed) (RFA-AG-25-032)
  Application due date: Multiple dates, see announcement.

More NIH funding opportunities focused on areas relevant to global health

NIH funding opportunities for which foreign organizations and/or foreign components of U.S. organizations may apply:

• Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed) (RFA-HG-25-007)
  Application due date: March 3, 2025
• In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems (UG3/UH3 Clinical Trials Not Allowed (RFA-RM-24-012)
  Application due date: March 7, 2025
• Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances funding opportunities:
  • R01 Clinical Trials Required (RFA-DA-26-003)
    Application due date: March 12, 2025
  • R34 Clinical Trials Required (RFA-DA-26-004)
    Application due date: March 12, 2025
• High-Priority Research in Tobacco Regulatory Science (R01 Clinical Trial Optional) (RFA-OD-25-001)
  Application due date: June 6, 2025
• NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders funding opportunities:
  • R33 CT Required (PAR-25-025)
    Application due date: Multiple dates, see announcement.
  • R61/R33 Clinical Trial Required (PAR-25-026)
    Application due date: Multiple dates, see announcement.
• Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional) (PAR-25-100)
  Application due date: Multiple dates, see announcement.
• Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns funding opportunities:
  • R01 - Clinical Trial Optional (PAR-25-265)
    Application due date: Multiple dates, see announcement.
  • R21 - Clinical Trial Optional (PAR-25-266)
    Application due date: Multiple dates, see announcement.
• Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) (PAR-25-297)
  Application due date: Multiple dates, see announcement.
• Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed) (PAR-25-300)
  Application due date: Multiple dates, see announcement.
• Artificial Intelligence in Pre-clinical Drug Development for AD/ADRD (R01 Clinical Trial Not Allowed) (RFA-AG-24-049)
  Application due date: Multiple dates, see announcement.
• Accelerating the Pace of Substance Use Research Using Existing Data funding opportunities:
  • R01 Clinical Trial Not Allowed (RFA-DA-26-055)
    Application due date: Multiple dates, see announcement.
  • R21 Clinical Trial Not Allowed (RFA-DA-26-056)
    Application due date: Multiple dates, see announcement.
• Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trials Not Allowed) (RFA-ES-25-003)
  Application due date: Multiple dates, see announcement.

NIH funding opportunities for which foreign components may apply:

• NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 Independent Clinical Trial Not Allowed) (PAR-24-286)
  Application due date: Multiple dates, see announcement.
• Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional) (PAR-24-330)
  Application due date: Multiple dates, see announcement.
• NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) (PAR-25-188)
  Application due date: Multiple dates, see announcement.
• NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed) (PAR-25-239)
  Application due date: Multiple dates, see announcement.
• NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) (PAR-25-251)
  Application due date: Multiple dates, see announcement.
• NCCIH Natural Product funding opportunities:
  • Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) (PAR-25-269)
    Application due date: Multiple dates, see announcement.
  • Early Phase Clinical Trial Award (R33 Clinical Trial Required) (PAR-25-270)
    Application due date: Multiple dates, see announcement.
  • Mid Phase Clinical Trial (R01 Clinical Trial Required) (PAR-25-271)
    Application due date: Multiple dates, see announcement.
• Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional) (PAR-25-299)
  Application due date: Multiple dates, see announcement.
• Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) (RFA-TR-25-002)
  Application due date: Multiple dates, see announcement.

Other Funding News

General Notices:

• Notice of Expiration of PA-21-235, NIMH Exploratory/Developmental Research Grant (R21 Clinical Trial Not Allowed) (NOT-MH-25-085)
• Notice of the Effectiveness and Services Trials Pre-Application Webinar for PAR-25-177, PAR-25-187, and PAR-25-285 (NOT-MH-25-105)

Notices of changes to NIH funding opportunities:

• Notice of Early Expiration of "Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes", NOT-AI-21-080 (NOT-AI-25-002)
• Notice of Early Expiration and Reissue of RFA-DA-25-056, "Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trials Not Allowed)" (NOT-DA-24-061)

Notices of intent to publish funding opportunities:

• Funding Opportunity for Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required) (NOT-AG-24-084)
• Funding Opportunity for Early- and Late-Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional) (NOT-AG-24-085)
• Funding Opportunity Announcement for Advancing Vision Health Equity through Multi-level Interventions and Community-Engaged Research (R01 - Clinical Trial Optional) (NOT-EY-25-002)

NIH Notices of Special Interest (NOSIs):

• Somatic Cell Gene Editing Therapies to Improve Transplantation Outcomes (NOT-AI-24-085)
  Expiration date: November 17, 2027
  

Non-NIH funding opportunities:

• The Scientific and Technological Research Council of Türkiye (TÜBİTAK) and The World Academy of Sciences (TWAS) have established a fellowship program for foreign scholars from developing countries in the South who wish to pursue postdoctoral research in a field of the natural and related applied sciences in the departments and laboratories of public and private universities of Türkiye (Turkey) and TÜBİTAK Research Centers and Institutes.
  Application deadline: December 16, 2024

More non-NIH funding opportunities

Training Opportunities

Cornell Accepting Applications for Global Women’s Health Training

Applications are now open for the Global Infectious Diseases across a Woman's Lifespan Course, and the Women’s Infectious Diseases in Global Health Scholars (WINGS) Program. 

• Applications due: January 31, 2025
• Apply here
  

Manuscript, Abstract & Poster Submission Opportunities

• The Research for Health in Humanitarian Crises (R2HC) Forum will be a 3-day event, held in Nairobi, Kenya between 7-9 May 2025, and co-hosted with the African Population Health Research Center (APHRC). Elrha is inviting humanitarian health research, policy, and practice experts, with experience relevant to the key objectives and themes of the Forum, to contribute to making it a stimulating, engaging, and inclusive event.
  • Submissions due: December 15, 2024
• The International Cancer Screening Network (ICSN) is now accepting abstract submissions for ICSN 2025, which will be held June 18-20, 2025 in Aarhus, Denmark. The theme of ICSN 2025 is "Shaping the Future of Cancer Screening." Submitters are encouraged to submit abstracts that explore topics relating to one of the 10 abstracts themes.
  • Submissions due: January 2, 2025
• The National Cancer Institute is now accepting proposals for the annual ASGCR Symposium on Global Cancer Research. The theme of this year’s symposium is New Models for Participatory Research in Global Oncology: Elevating the Voices of Patients and Providers.
  • Symposium dates: May 5-8, 2025
  • Submissions due: January 17, 2025
• The Abstract Submission portal for INTEREST 2025, being held May 13-16, 2025, in Windhoek, Namibia, is now open. Successful candidates will be invited for an oral, mini-oral, or poster presentation.
  • Submissions due: January 17, 2025
• Beyond Global Health (BGH) is interested in how people from the Global North and Global South share their understanding of the concept of “Global Health.” Rather than exploring this through scientific journals and manuscripts, BGH is looking to expand on this idea through poetry, art, prose, and photography. Submissions are currently being accepted through the BGH website from researchers, participants, global health professionals, recipients of global health interventions, and anyone passionate about global health.
  • Submissions due: February 17, 2025

Events

Events for global health researchers:

• 17th Annual Conference on the Science of Dissemination and Implementation in Health

  • Date: December 8-11
  • Location: Arlington, VA
  • Hosted by NIH and Academy Health

• Equity in Global Health Partnerships

  • Date: December 11
  • Location: Washington, DC and Virtual
  • Hosted by Results for Development

• A Partnership to Catalyze Hepatitis Elimination in the Philippines and Strengthen Primary Healthcare

  • Date: December 13
  • Location: Virtual
  • Hosted by Harvard Global Health Institute

Fogarty calendar of events